MD
Publicaties op Oncologisch.com
Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negati...
Adjuvant T-DM1 versus paclitaxel-trastuzumab bij stadium I HER2-positief: ATEMPT vijfjaars
Fulvestrant-palbociclib-avelumab na CDK4/6-progressie bij mammacarcinoom: PACE fase II
Adjuvant T-DM1 versus paclitaxel-trastuzumab bij stadium I HER2-positief: ATEMPT fase II